Document is current
Any future updates will be listed below
-
Authors
Laitinen, Iina https://orcid.org/0000-0002-1362-7625
Litorp, Helena
Sjöberg, Folke
Ekström, Simon
Haraldsson, Henrik https://orcid.org/0000-0003-2363-2994
Pierrou, Stefan
Korenyushkin, Alexander https://orcid.org/0009-0003-9678-5016
Kullberg, Joel https://orcid.org/0000-0001-8205-7569
Southekal, Sudeepti
Lu, Ming
Coskun, Tamer
Milicevic, Zvonko
Johansson, Lars https://orcid.org/0000-0001-5954-3497
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 1 March 2024
Accepted: 24 July 2025
First Online: 7 August 2025
Declarations
:
: The study was performed in accordance with ethical principles that have their origin in the Declaration of Helsinki. Approval was granted by the Swedish Ethical Review Authority (Etikprövningsmyndigheten, Uppsala, Sweden), Drn 2020-04140, including radiation safety authority (drn SSM2020-5219). Informed consent was obtained from all individual participants included in the study.
: Written informed consent for publication was obtained.
: Employments at the time of study: Iina Laitinen, Simon Ekström, Henrik Haraldsson, Stefan Pierrou, Alexander Korenyushkin, Joel Kullberg and Lars Johansson by Antaros Medical AB, Mölndal, Sweden; Helena Litorp and Folke Sjöroos by Clinical Trial Consultants CTC, Uppsala, Sweden; Sudeepti Southekal, Ming Lu, Tamer Coskun and Zvonko Milicevic by Eli Lilly and company.
